Notes on Skin
XERF is marketed for mild to moderate skin laxity, including early jowling and loss of jawline definition, and is commonly suited to patients in their 30s–50s noticing first signs of skin descent. It is a non-invasive radiofrequency treatment that does...
XERF is a non-invasive monopolar radiofrequency device that delivers energy at 6.78 MHz and 2 MHz through handpiece tips without needles or ablation. Preclinical studies in porcine tissue and small human trials have shown thermal effects in dermal and subdermal...
XERF is a non-invasive monopolar radiofrequency device used for skin tightening. Early human studies report short-term improvement, but longer-term XERF-specific durability is not yet established. The device includes impedance feedback and adjustable parameters, but these features do not guarantee improved...
Exosome facials are being studied primarily in pharmaceutical, biotech, and academic research settings for their potential in regenerative medicine, disease diagnosis, and biomarker discovery. While early research shows promise for exosomes' therapeutic potential in skin rejuvenation, most clinical evidence remains...
Los Angeles has emerged as a major market for exosome facial treatments, driven by the city's longstanding culture of early adoption in aesthetics, a large population seeking advanced skin rejuvenation, and an industry infrastructure that supports innovation. The data shows...